Zydus Lifesciences Ltd (BOM:532321)
₹ 1045.1 -5.25 (-0.5%) Market Cap: 1.05 Til Enterprise Value: 1.04 Til PE Ratio: 27.85 PB Ratio: 5.39 GF Score: 95/100

Q2 2021 Cadila Healthcare Ltd Earnings Call Transcript

Nov 02, 2020 / 12:45PM GMT
Release Date Price: ₹410.15 (-1.81%)
Operator

Ladies and gentlemen, good day, and welcome to the Q2 FY '21 Post Results Conference Call of Cadila Healthcare Limited. (Operator Instructions) I now hand the conference over to Mr. Ganesh Nayak, COO and Executive Director. Thank you, and over to you.

Ganesh Narayan Nayak
Cadila Healthcare Limited - COO & Executive Director

Good evening, ladies and gentlemen. Welcome to our post results teleconference for the quarter ended September 30, 2020. We wish you and your family are safe and healthy during these times. For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Harish Sadana, Chief Strategy Officer; and Mr. Vishal Gor, Senior Vice President, Corporate Finance.

During the quarter, the spread of COVID-19 continued unabated across the globe, and in turn, continued to impact the economy and businesses across countries. However, we now consider it as the new normal. And by use of technology and newer methods, we continue to endeavor to improve all facets of our business beyond pre-COVID

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot